This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Janulionis, E.
Right arrow Articles by Wallis, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janulionis, E.
Right arrow Articles by Wallis, R. S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2004, p. 3133-3135, Vol. 48, No. 8
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.8.3133-3135.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Lack of Activity of Orally Administered Clofazimine against Intracellular Mycobacterium tuberculosis in Whole-Blood Culture

Ernestas Janulionis, Carolina Sofer, Ho-Yeon Song, and Robert S. Wallis*

University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey

Received 25 February 2004/ Returned for modification 22 March 2004/ Accepted 26 April 2004

The activity of oral clofazimine against intracellular Mycobacterium tuberculosis was compared to that of ofloxacin in healthy volunteers by the use of whole-blood cultures. Clofazimine was inactive whether it was tested alone or combined with other drugs that are used to treat multidrug-resistant tuberculosis, despite a total dose of 2 g. Kanamycin was the most active drug tested.

* Corresponding author. Mailing address: Department of Medicine, UMDNJ-NJMS, MSB I-503, 185 S. Orange Ave., Newark, NJ 07103. Phone: (973) 972-8778. Fax: (973) 972-8878. E-mail: r.wallis{at}umdnj.edu.

Antimicrobial Agents and Chemotherapy, August 2004, p. 3133-3135, Vol. 48, No. 8
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.8.3133-3135.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Mitnick, C. D., Shin, S. S., Seung, K. J., Rich, M. L., Atwood, S. S., Furin, J. J., Fitzmaurice, G. M., Alcantara Viru, F. A., Appleton, S. C., Bayona, J. N., Bonilla, C. A., Chalco, K., Choi, S., Franke, M. F., Fraser, H. S.F., Guerra, D., Hurtado, R. M., Jazayeri, D., Joseph, K., Llaro, K., Mestanza, L., Mukherjee, J. S., Munoz, M., Palacios, E., Sanchez, E., Sloutsky, A., Becerra, M. C. (2008). Comprehensive Treatment of Extensively Drug-Resistant Tuberculosis. NEJM 359: 563-574 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»